Latest Buzz

• Gene Ray, Founder of $2.6 Billion Titan Corp, Invests in Medistem’s ERC Technology and Joins Advisory Board
• Medistem Industry/Academia Collaboration Leads to Nanotechnology Based “Cancer Vaccine”
• Entest BioMedical Excited With Progress on 10 Dog Pilot Study of “Universal Donor” Stem Cell Treatment for Canine Osteoarthritis
• Medistem Shareholder Update: March 2012
• Medistem Signs Exclusive Worldwide License With Yale University for Treatment of Type 1 Diabetes Using Stem Cells